Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

CinCor Pharma Inc (CINC) Stock Forecast 2025 - AI Price Prediction & Analysis

CinCor Pharma Inc (CINC) AI Stock Price Forecast & Investment Analysis

CinCor Pharma Inc Stock Price Chart and Technical Analysis

Loading CinCor Pharma Inc interactive price chart and technical analysis...

CinCor Pharma Inc (CINC) - Comprehensive Stock Analysis & Investment Research

Deep dive into CinCor Pharma Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about CinCor Pharma Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For CinCor Pharma Inc: CinCor Pharma Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

CinCor Pharma Inc (Stock Symbol: CINC) is a leading company in the Manufacturing sector , specifically operating within the Medicinal and Botanical Manufacturing industry.

The organization employs approximately 21 professionals worldwide and operates under the strategic leadership of CEO Marc de Garidel.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing CinCor Pharma Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CinCor Pharma Inc:

Market Capitalization: $1272 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -19.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for CinCor Pharma Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For CinCor Pharma Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CinCor Pharma Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: CinCor Pharma Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For CinCor Pharma Inc: Market positioning analysis based on available financial and operational metrics.

CinCor Pharma Inc strategically competes in the highly dynamic Medicinal and Botanical Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

CinCor Pharma Inc (CINC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CinCor Pharma Inc stock analysis.

Loading CinCor Pharma Inc comprehensive fundamental analysis and insider trading data...

Deep dive into CinCor Pharma Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if CinCor Pharma Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For CinCor Pharma Inc: With a P/E ratio of -10.35, the market sees the stock as potentially undervalued.

P/E Ratio -10.35x
P/B Ratio 2.45x
Market Cap $1272M
EPS $-1.63
Book Value/Share $11.86
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently CinCor Pharma Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CinCor Pharma Inc: An ROE of -19.5% indicates room for improvement in shareholder value creation.

ROE -19.5%
ROA -19.1%
ROIC -19.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess CinCor Pharma Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For CinCor Pharma Inc: A current ratio of 56.57 indicates strong liquidity.

Current Ratio 56.57x
Quick Ratio 55.25x
Financial Leverage 1.02x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal CinCor Pharma Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For CinCor Pharma Inc: Free cash flow of $-43M indicates cash challenges that need attention.

Operating Cash Flow $-43M
Free Cash Flow $-43M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively CinCor Pharma Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For CinCor Pharma Inc:

Understanding Financial Statement Data

What these metrics mean: Key figures from CinCor Pharma Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For CinCor Pharma Inc:

Income Statement ($ Millions)
Operating Income $-52M
Net Income $-61M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 100%
Cash & Short-term Investments 98%
Total Liabilities 2%
Dividend & Shareholder Information
Shares Outstanding 44M

Latest CinCor Pharma Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting CinCor Pharma Inc (CINC) stock price and investment outlook.

, source: Reuters

On the face of it, Pascal Soriot’s new deal ought to raise his shareholders’ blood pressure. The boss of $221 billion pharma giant AstraZeneca has agreed to buy CinCor Pharma for up to $1.8 billion.

, source: Seeking Alpha

WALTHAM, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (CINC) today announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to ...

, source: BioWorld

Parties to Astrazeneca plc’s potential $1.8 billion takeover of Cincor Pharma Inc. are keeping mum about contingent value rights included in the deal for baxdrostat, the phase III-bound aldosterone ...

, source: Nature

More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better ...

CinCor Pharma Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of CinCor Pharma Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - CinCor Pharma Inc Stock Forecast

How accurate are CinCor Pharma Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for CINC predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence CinCor Pharma Inc stock price forecasts?

Our analysis considers CinCor Pharma Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is CinCor Pharma Inc a good investment in 2025?

Based on our AI analysis, CinCor Pharma Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are CinCor Pharma Inc forecasts updated?

CinCor Pharma Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced CinCor Pharma Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CinCor Pharma Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...